BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 15365985)

  • 1. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pick's complex and FTDP-17.
    Kertesz A
    Mov Disord; 2003 Sep; 18 Suppl 6():S57-62. PubMed ID: 14502657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The G389R mutation in the MAPT gene presenting as sporadic corticobasal syndrome.
    Rossi G; Marelli C; Farina L; Laurà M; Maria Basile A; Ciano C; Tagliavini F; Pareyson D
    Mov Disord; 2008 Apr; 23(6):892-5. PubMed ID: 18307268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].
    Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T
    No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, pathological, and genetic characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in the MAPT and PGRN].
    Tsuboi Y
    Brain Nerve; 2009 Nov; 61(11):1285-91. PubMed ID: 19938685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.
    Zarranz JJ; Ferrer I; Lezcano E; Forcadas MI; Eizaguirre B; Atarés B; Puig B; Gómez-Esteban JC; Fernández-Maiztegui C; Rouco I; Pérez-Concha T; Fernández M; Rodríguez O; Rodríguez-Martínez AB; de Pancorbo MM; Pastor P; Pérez-Tur J
    Neurology; 2005 May; 64(9):1578-85. PubMed ID: 15883319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic heterogeneity within a new family with the MAPT p301s mutation.
    Yasuda M; Nakamura Y; Kawamata T; Kaneyuki H; Maeda K; Komure O
    Ann Neurol; 2005 Dec; 58(6):920-8. PubMed ID: 16240366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region.
    Cruts M; Rademakers R; Gijselinck I; van der Zee J; Dermaut B; de Pooter T; de Rijk P; Del-Favero J; van Broeckhoven C
    Hum Mol Genet; 2005 Jul; 14(13):1753-62. PubMed ID: 15888485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical, genetic and pathological aspects of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Tsuboi Y
    Rinsho Shinkeigaku; 2004 Nov; 44(11):875-8. PubMed ID: 15651319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies.
    Umeda Y; Taniguchi S; Arima K; Piao YS; Takahashi H; Iwatsubo T; Mann D; Hasegawa M
    Neurosci Lett; 2004 Apr; 359(3):151-4. PubMed ID: 15050686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.
    van der Zee J; Rademakers R; Engelborghs S; Gijselinck I; Bogaerts V; Vandenberghe R; Santens P; Caekebeke J; De Pooter T; Peeters K; Lübke U; Van den Broeck M; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C; Dermaut B
    Brain; 2006 Apr; 129(Pt 4):841-52. PubMed ID: 16495329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of MAPT haplotype diversity in frontotemporal dementia.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Ibach B; Bäuml J; Eisele T; Förstl H; Kurz A; Riemenschneider M
    Neurobiol Aging; 2008 Aug; 29(8):1276-8. PubMed ID: 17386961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPT gene duplications are not a cause of frontotemporal lobar degeneration.
    Lladó A; Rodríguez-Santiago B; Antonell A; Sánchez-Valle R; Molinuevo JL; Reñé R; Pérez-Jurado LA
    Neurosci Lett; 2007 Aug; 424(1):61-5. PubMed ID: 17707586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau protein and neurodegeneration.
    Goedert M
    Semin Cell Dev Biol; 2004 Feb; 15(1):45-9. PubMed ID: 15036206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
    Hasegawa M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.